Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07143487 · ClinicalTrials.gov registry record · NA
Family Communications After Genetic Testing
A NA study, sponsored by Alliance for Clinical Trials in Oncology.
- Recruiting
- Registry status
- NA
- Development phase
- 4,186
- Enrollment target
NCT07143487 is a NA study that is actively recruiting participants, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 4,186 participants.
The verdict
NCT07143487, a NA study, is actively recruiting participants, sponsored by Alliance for Clinical Trials in Oncology.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,186 participants
- Enrollment target
Study Summary
This clinical trial compares patient (proband)-mediated communication to provider-mediated communication for improving genetic testing in first-degree relatives of patients with newly diagnosed colorectal cancer. It is estimated that 30% of cases of colorectal cancer have a genetic basis and about 15% of these patients have a disease-causing (pathogenic) inherited (germline) variant in a cancer susceptibility gene. Most individuals carrying a pathogenic germline variant are unaware of their cancer risk and may not meet guidelines for genetic testing. Identifying pathogenic germline variants or hereditary cancer syndromes in cancer patients has important implications for their at-risk relatives who may not know that they are at high risk for cancer. The burden of communicating this risk to first-degree relatives often falls on the patients, who may lack sufficient knowledge to correctly share and explain their genetic test results. Receiving provider-mediated communication of genetic testing results may be more effective at communicating genetic risk to first-degree relatives than the usual practice of proband-mediated communication.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Survey Administration
- OTHER Communication Intervention
- OTHER Genetic Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,186 participants |
| Start Date | 2026-04-06 |
| Est. Completion | 2032-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07143487
The ClinicalTrials.gov registry entry for NCT07143487 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 4,186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT07143487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07143487 about?
NCT07143487 is a clinical study titled "Family Communications After Genetic Testing". This clinical trial compares patient (proband)-mediated communication to provider-mediated communication for improving genetic testing in first-degree relatives of patients with newly diagnosed colorectal cancer. It is estimated that 30% of cases of colorectal cancer have a genetic basis and about 1...
What is the current status of trial NCT07143487?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,186 participants. The study started on 2026-04-06. Estimated completion is 2032-11-05.
What interventions are being tested in trial NCT07143487?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Communication Intervention (OTHER), Genetic Testing (OTHER).
Who is sponsoring clinical trial NCT07143487?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.